PRIALT (ziconotide acetate)
ANALGESIC, NEURONAL-TYPE CALCIUM CHANNEL BLOCKER · SEVERE CHRONIC PAIN
TERSERA THERAPE
Drug class
Analgesic, Neuronal-type Calcium Channel Blocker
The drug class commonly referenced as analgesic neuronal-type (or N-type) calcium channel blockers encompasses non-opioid antinociceptive agents, most notably represented by ziconotide. Read more about Analgesic, Neuronal-type Calcium Channel Blocker
1 drugs in this class 1 manufacturers
Drugs in Analgesic, Neuronal-type Calcium Channel Blocker
Filter & compare in the drug finder →
Opens the drug finder with Analgesic, Neuronal-type Calcium Channel Blocker preselected. Add indication or manufacturer filters there.
The drug class commonly referenced as analgesic neuronal-type (or N-type) calcium channel blockers encompasses non-opioid antinociceptive agents, most notably represented by ziconotide.
These agents function by selectively binding to voltage-gated, presynaptic N-type calcium channels (CaV2.2) located on primary nociceptive afferent nerves within the superficial dorsal horn of the spinal cord.
This selective inhibition halts the influx of calcium and prevents the release of excitatory neurotransmitters, such as substance P and glutamate, thereby suppressing the transmission of pain signals to the brain.
Therapeutically, this class is administered intrathecally for the management of severe, intractable chronic pain in patients who are intolerant of or refractory to other treatments, including systemic analgesics and intrathecal opioids.
-
nih.gov
The drug class commonly referenced as analgesic neuronal-type (or N-type) calcium channel blockers encompasses non-opioid antinociceptive agents, most notably represented by ziconotide Therapeutically, this class is administered intrathecally for the management of severe, intractable chronic pain in patients who are intolerant of or refractory to other treatments, including systemic analgesics and intrathecal opioids
-
molinaclinicalpolicy.com
The drug class commonly referenced as analgesic neuronal-type (or N-type) calcium channel blockers encompasses non-opioid antinociceptive agents, most notably represented by ziconotide This selective inhibition halts the influx of calcium and prevents the release of excitatory neurotransmitters, such as substance P and glutamate, thereby suppressing the transmission of pain signals to the brain
-
fiercebiotech.com
These agents function by selectively binding to voltage-gated, presynaptic N-type calcium channels (CaV2.2) located on primary nociceptive afferent nerves within the superficial dorsal horn of the spinal cord
-
researchgate.net
These agents function by selectively binding to voltage-gated, presynaptic N-type calcium channels (CaV2.2) located on primary nociceptive afferent nerves within the superficial dorsal horn of the spinal cord
-
upmc.com
This selective inhibition halts the influx of calcium and prevents the release of excitatory neurotransmitters, such as substance P and glutamate, thereby suppressing the transmission of pain signals to the brain
-
aetna.com
Therapeutically, this class is administered intrathecally for the management of severe, intractable chronic pain in patients who are intolerant of or refractory to other treatments, including systemic analgesics and intrathecal opioids
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.